FDA Warning Letter — Guangzhou Baiyunshan Pharmaceutical Co., Ltd.
The FDA took a Warning Letter action against Guangzhou Baiyunshan Pharmaceutical Co., Ltd. on November 1, 2017 (Guangzhou, China). The action was issued by CDER and concerns drugs products. This facility has 1 recent FDA inspection on record.
Action Details
- Facility
- Guangzhou Baiyunshan Pharmaceutical Co., Ltd.
- Date
- November 1, 2017
- Fiscal Year
- 2018
- Product Type
- Drugs
- Center
- CDER
- Location
- Guangzhou (China)